Analyst Ratings for BioCryst Pharma (BCRX)
BCRX Rating Summary
BCRX Price Target Summary
- Highest: $32.00 (H.C. Wainwright)
- Lowest: $9.00 (Barclays)
- Average: $20.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.30 (+118.5%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
Avg. $ Target:
$20.30 (+118.5%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | JPMorgan | Jessica Fye | New Coverage | Neutral (N/A) |
12.00 (N/A) |
10.72 (9.29) |
-13.34% | Details |
| 2/18/2026 | Evercore ISI | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
17.00 (N/A) |
6.95 (9.29) |
33.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
